Paper Review Records
全部论文审稿周期
1 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
50
天
SLC39A8 Inhibits Ferroptosis by Regulating the Β-Catenin/TCF4/ GPX4 Signaling in Osteosarcoma
作者
Siliang Tang; Guojun Tang; Liangyuan Chen; Mingjiang Luo; Jingshan Huang; Zihan Zhang; Shuo Wen; Zhihong Xiao展开收起
作者单位
1. Department of Spine Surgery, the Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001 , China ;; 2. Department of Union Hospital, West Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430000, Hubei , China ;; 3. Department of Spine Surgery, Lishui Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, 323050 , China展开收起
FAQ
CURRENT MOLECULAR MEDICINE审稿要多久?
截至2026-11-19,CrushSCI 只收录了 CURRENT MOLECULAR MEDICINE 的 1 篇完整审稿记录:SLC39A8 Inhibits Ferroptosis by Regulating the Β-Catenin/TCF4/ GPX4 Signaling in Osteosarcoma,2025-05-06 收稿,2025-06-25 录用,审稿 50 天。只有一篇样本,结果仅供参考。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
